Ophthalmology Times - ophthalmology news, articles, and events in a timely and accurate manner for members of the ophthalmic ...

Nearly two years after reporting successful results from a phase 3 trial of its oral version of injected obesity treatment ...

With Semaglutide, postmenopausal women can achieve significant weight loss, improve insulin sensitivity, and lower the risk ...

Researchers warned that to achieve such reductions, greater uptake of the medication among indicated patients is needed.

Compounded semaglutide has not gone through the same review process as FDA-approved drugs, so it is unclear how safe or effective these products are. It’s important to get a prescription for ...

Trial confirms that oral semaglutide lowers cardiovascular risk in type 2 diabetes, regardless of SGLT2i use. Read more!

Semaglutide was initially approved under the brand name Ozempic for Type 2 diabetes, while the brand name Wegovy is only approved for weight loss. Here, we’ll compare tirzepatide (Zepbound ...

It has expanded its offerings to include weight loss, focusing on prescription medications, including its own compounded semaglutide ... on about 3,600 customer reviews, it has an A+ rating ...

Novo Nordisk has said it is accelerating launch preparations for its new diabetes pill semaglutide, after investing in a voucher that will allow a fast review of the drug in the US.